CN103655350A - Folium mugwort essential oil containing bath salt - Google Patents
Folium mugwort essential oil containing bath salt Download PDFInfo
- Publication number
- CN103655350A CN103655350A CN201310698354.3A CN201310698354A CN103655350A CN 103655350 A CN103655350 A CN 103655350A CN 201310698354 A CN201310698354 A CN 201310698354A CN 103655350 A CN103655350 A CN 103655350A
- Authority
- CN
- China
- Prior art keywords
- bath salt
- cymene
- sodium
- salt
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000019341 magnesium sulphate Nutrition 0.000 title claims abstract description 27
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 title claims abstract description 26
- 239000000341 volatile oil Substances 0.000 title abstract description 5
- 240000006891 Artemisia vulgaris Species 0.000 title abstract 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 title abstract 4
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 15
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 claims abstract description 10
- 235000018341 sodium sesquicarbonate Nutrition 0.000 claims abstract description 10
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 claims abstract description 10
- 239000011780 sodium chloride Substances 0.000 claims abstract description 8
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 19
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 claims description 10
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 claims description 9
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 claims description 9
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 claims description 9
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 claims description 9
- 229960000271 arbutin Drugs 0.000 claims description 9
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 claims description 9
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 9
- 230000002087 whitening effect Effects 0.000 claims description 9
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 claims description 8
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 235000019864 coconut oil Nutrition 0.000 claims description 7
- 239000003240 coconut oil Substances 0.000 claims description 7
- RRLOOYQHUHGIRJ-UHFFFAOYSA-M sodium;ethyl sulfate Chemical compound [Na+].CCOS([O-])(=O)=O RRLOOYQHUHGIRJ-UHFFFAOYSA-M 0.000 claims description 6
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims description 4
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 claims description 2
- 240000007440 Agaricus campestris Species 0.000 claims description 2
- 235000004570 Agaricus campestris Nutrition 0.000 claims description 2
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 claims description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 2
- 229960004705 kojic acid Drugs 0.000 claims description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims description 2
- 239000004137 magnesium phosphate Substances 0.000 claims description 2
- 229960002261 magnesium phosphate Drugs 0.000 claims description 2
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims description 2
- 235000010994 magnesium phosphates Nutrition 0.000 claims description 2
- 229930002330 retinoic acid Natural products 0.000 claims description 2
- 239000001488 sodium phosphate Substances 0.000 claims description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 2
- 229960001727 tretinoin Drugs 0.000 claims description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 2
- 239000011734 sodium Substances 0.000 abstract description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 3
- 239000011148 porous material Substances 0.000 abstract description 3
- 229910052708 sodium Inorganic materials 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract description 2
- TXQVDVNAKHFQPP-UHFFFAOYSA-N [3-hydroxy-2,2-bis(hydroxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)(CO)CO TXQVDVNAKHFQPP-UHFFFAOYSA-N 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 230000003796 beauty Effects 0.000 description 4
- 230000036564 melanin content Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OTYVBQZXUNBRTK-UHFFFAOYSA-N 3,3,6-trimethylhepta-1,5-dien-4-one Chemical compound CC(C)=CC(=O)C(C)(C)C=C OTYVBQZXUNBRTK-UHFFFAOYSA-N 0.000 description 2
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 2
- SBLKVIQSIHEQOF-UPHRSURJSA-N Octadec-9-ene-1,18-dioic-acid Chemical compound OC(=O)CCCCCCC\C=C/CCCCCCCC(O)=O SBLKVIQSIHEQOF-UPHRSURJSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 241001625808 Trona Species 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000007791 dehumidification Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- AFHJQYHRLPMKHU-GIWDNFATSA-N 1,8-dihydroxy-3-(hydroxymethyl)-10-[(3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10h-anthracen-9-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-GIWDNFATSA-N 0.000 description 1
- GOKHLKYATMBASR-UHFFFAOYSA-N 2-(4-methylcyclohexyl)propan-1-ol Chemical compound OCC(C)C1CCC(C)CC1 GOKHLKYATMBASR-UHFFFAOYSA-N 0.000 description 1
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 1
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102100039094 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940116918 octadecenedioic acid Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940086560 pentaerythrityl tetrastearate Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses folium mugwort essential oil containing bath salt which comprises the components in parts by weight as follows: 1-3 parts of folium mugwort essential oil, 4-8 parts of sodium cocomonoglyceride sulfate, 0.4-0.8 part of pentaerythritol stearate, 20-40 parts of sodium chloride and 60-80 parts of sodium sesquicarbonate. The folium mugwort essential oil containing bath salt has the functions of removing pore dirt of a human body, warming and activating meridian and dispelling cold and dampness.
Description
Technical field:
The present invention relates to a kind of bath salt, particularly a kind of P-Cymene bath salt.
Background technology:
In beauty treatment industry, use salt beauty treatment to have very long history.The salt of beauty treatment use adopts untreated crude salt mostly, because this salt particle is large, is unlikely to fast instantizing when smearing, and skin is had to certain massage effect.Also, because they do not pass through polish, natural minerals composition is more, more beneficial to skin.It is strong that fine salt has permeability, can deep layer dissolve dirt, the functions such as anti-acne.
Conventionally bath salt is become to be grouped into by medical herbs, natural sea salt, mineral and plants essential oil etc., be rich in the various trace elements such as ferrum, calcium, selenium, magnesium of needed by human body, life-time service bath salt can be eliminated the melanin on skin, allow skin recover gradually tenderly white, soft, elasticity, to dispelling facial skin sore, acne, mottle, also have positive effect.
The effect of bath salt is the permeability that utilizes salt, go deep into skin, impel blood circulation, enhance metabolism, take moisture unnecessary in pore and fine material, fat etc. out of, play the effect of weight-reducing, utilize the scrub of salt, remove the cutin of skin surface, the skin that thirst smoothly comes off, delay skin aging, plays the effect of body building and beauty treatment.
P-Cymene, adopt vapor distillation etc. the quintessence oil that extracts from Folium Artemisiae Argyi of method.Contain characteristic component: australene, nopinene, α-terpinene, γ-terpinene, cineole, artemisia ketone, artemisol, 2-cyclohexene-1-alcohol, Camphora, Borneolum Syntheticum, 4-terpineol, trans-caryophyllene, acetaminol.The good result with promoting the flow of QI in the collateral by warming the meridian, dispelling cold and dehumidification, has more significant effect for the crowd of women and hypoimmunity.
Yet existing commercially available prod, do not have by quintessence oil particularly P-Cymene and bath salt composite.
Summary of the invention:
For prior art above shortcomings, technical problem to be solved by this invention is to provide a kind of P-Cymene bath salt.
Technical problem of the present invention, is achieved by following technical proposals:
A P-Cymene bath salt, comprises the component of following weight parts: 1-3 part P-Cymene, 4-8 part coconut oil monoglyceride sodium sulfovinate, 0.4-0.8 part pentaerythritol tetrastearate, 20-40 part sodium chloride, 60-80 part sodium sesquicarbonate.
Preferably,
A P-Cymene bath salt, comprises the component of following weight parts: 1-3 part P-Cymene, 4-8 part coconut oil monoglyceride sodium sulfovinate, 0.4-0.8 part pentaerythritol tetrastearate, 20-40 part sodium chloride, 60-80 part sodium sesquicarbonate, 0.05-0.15 part whitening agent.
Described whitening agent is a kind of or its mixture in Azelaic Acid, retinoic acid, phloretin, Agaricus campestris extract, Vc sodium phosphate, Vc magnesium phosphate, kojic acid, octadecene diacid, arbutin, barbaloin and Licochalcone A.
Optimum, described whitening agent consists of by weight following component: 10-30 part octadecene diacid, 10-30 part arbutin, 10-30 part barbaloin and 30-50 part Licochalcone A.
Sodium sesquicarbonate, also claims " sodium sesquicarbonate ".Chemical formula Na
2cO
3naHCO
32H
2o, English name: sodium sesquicarbonate.At occurring in nature, be present in the deposit in salt lake, be called " trona " or " trona ".
Coconut oil monoglyceride sodium sulfovinate, Sodium Cocomonoglyceride Sulfate, No. CAS: 61789-04-6.
Pentaerythritol tetrastearate, PENTAERYTHRITYL TETRASTEARATE, No. CAS: 115-83-3.
Octadecene diacid, has another name called: octadecene diacid, English name: OCTADECENEDIOIC ACID, CAS accession number: 20701-68-2.Octadecene diacid what take off that black mechanism finds at present is mainly to stimulate Pexoxisome proliferator receptor (PPAR).After being combined with PPAR, thereby the MRNA that can reduce tryrosinase expresses the black effect that presses down of playing.
Arbutin, has another name called Arbutin, the acicular crystal that is white in color or powder.Extraction, from the leaf of Folium Vaccinii vitis-idaeae, can be accelerated melanic decomposition and excretion, thereby reduces Skin pigmentation, and dispelling stain and freckle also have the effect of sterilization, antiinflammatory simultaneously.English name: Arbutin, CAS accession number: 497-76-7.
Barbaloin, CAS accession number: 5133-19-7, English name: Aloin, claims again: 10-glucopyranosyl-1,8-dihydroxy-3-methylol-9 (10H)-anthrone.
Licochalcone A, English name: Licochalcone A, CAS accession number: 58749-22-7.Licochalcone A can restraint of tyrosinase, can suppress again dopachrome interconvertible enzyme and DHICA oxidase, and also have and significantly remove free radical and antioxidation, be a kind of additive of whitening cosmetics fast and efficiently.
If no special instructions, in the present invention related raw material all in working substance content 100%.Obviously can also add other raw materials in the present invention, as chelating agen, antibacterial, pigment, essence etc., other raw materials add realizes its function separately substantially, conventionally can not affect key property of the present invention.
P-Cymene bath salt of the present invention can adopt industry universal method to be prepared from, for example, directly each component is uniformly mixed, and can make this P-Cymene bath salt.
P-Cymene bath salt of the present invention has certain cleaning force, can remove human body pore dirt, promoting the flow of QI in the collateral by warming the meridian, dispelling cold and dehumidification.Further, owing to having added whitening agent, can eliminate the melanin on skin, allow skin recover gradually tenderly white.
The specific embodiment:
Embodiment further illustrates of the present invention below, rather than limits the scope of the invention.In the present invention, if no special instructions, each raw material all be take working substance content as 100%.
Embodiment 1
Take: 2 kilograms of P-Cymenes, 6 kilograms of coconut oil monoglyceride sodium sulfovinates, 0.6 kilogram of pentaerythritol tetrastearate, 30 kilograms of sodium chloride, 70 kilograms of sodium sesquicarbonate.Above-mentioned raw materials is at room temperature uniformly mixed, can makes P-Cymene bath salt of the present invention.
Embodiment 2-6
By the embodiment 2-6 data of table 1 correspondence, take each raw material respectively.Each raw material is at room temperature uniformly mixed, can makes P-Cymene bath salt of the present invention.
Table 1: bath salt formula table unit: kilogram
| ? | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 |
| P-Cymene | 2 | 2 | 2 | 2 | 2 |
| Coconut oil monoglyceride sodium sulfovinate | 6 | 6 | 6 | 6 | 6 |
| Pentaerythritol tetrastearate | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
| Sodium chloride | 30 | 30 | 30 | 30 | 30 |
| Sodium sesquicarbonate | 70 | 70 | 70 | 70 | 70 |
| Octadecene diacid | 0.02 | / | 0.02 | 0.02 | 0.06 |
| Arbutin | 0.02 | 0.04 | / | 0.02 | 0.02 |
| Barbaloin | 0.02 | 0.02 | 0.04 | / | 0.02 |
| Licochalcone A | 0.04 | 0.04 | 0.04 | 0.06 | / |
Test case:
25 volunteers are selected in experiment altogether, measure melanin content in human body skin, and the white-skinned face function of bath salt product is evaluated.
5 Healthy Peoples are selected in every group of test, age is in 18-40 year, sign Informed Consent Form with study subject, the MEXAMETERMX18 skin pigment instrument that adopts German Courage+Khazaka company is using bath salt first 1 day and is using continuously bath salt within 21 days, to measure afterwards the melanin content of skin outside its arm.Measure environment: test environment temperature (22 ± 1) ℃, humidity (50 ± 5) %, averages.Study subject is used bath salt product to take a shower every day, and bathing method is: in bathtub, put into the water of 40 ℃, and add 10 grams of bath salts, study subject is taken a shower in bathtub.Study subject is not used other whitening products and cleaning product at test period.
This instrument of MEXAMETER MX18 skin pigment instrument is the principle (RGB) based on spectral absorption, and the volume reflection of the illumination by measuring specific wavelength after on human body skin determined melanic content in skin.The emitter of instrument probe sends rayed that wavelength is respectively 568nm, 660nm and tri-kinds of wavelength of 880nm at skin surface, and accepter records the light of skin reflex.Because radiative amount is certain, therefore just can measure the amount of the light being absorbed by the skin, measure the content of dermal melanin.The measuring range of instrument is 0-999, measures numerical value higher, illustrates that in skin, melanin content is higher.
Table 2: test data table
The test data of experiment of associative list 2, can find out significantly: the present invention is initiatively by the composite use of octadecene diacid, arbutin, barbaloin and Licochalcone A, for white-skinned face function, played obvious synergistic function, its mechanism needs inventor and further studies.
Claims (4)
1. a P-Cymene bath salt, is characterized in that, comprises the component of following weight parts: 1-3 part P-Cymene, 4-8 part coconut oil monoglyceride sodium sulfovinate, 0.4-0.8 part pentaerythritol tetrastearate, 20-40 part sodium chloride, 60-80 part sodium sesquicarbonate.
2. salt as claimed in claim 1, is characterized in that, comprises the component of following weight parts: 1-3 part P-Cymene, 4-8 part coconut oil monoglyceride sodium sulfovinate, 0.4-0.8 part pentaerythritol tetrastearate, 20-40 part sodium chloride, 60-80 part sodium sesquicarbonate, 0.05-0.15 part whitening agent.
3. P-Cymene bath salt as claimed in claim 2, it is characterized in that, described whitening agent is a kind of or its mixture in Azelaic Acid, retinoic acid, phloretin, Agaricus campestris extract, Vc sodium phosphate, Vc magnesium phosphate, kojic acid, octadecene diacid, arbutin, barbaloin and Licochalcone A.
4. P-Cymene bath salt as claimed in claim 3, is characterized in that, described whitening agent consists of by weight following component: 10-30 part octadecene diacid, 10-30 part arbutin, 10-30 part barbaloin and 30-50 part Licochalcone A.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310698354.3A CN103655350B (en) | 2013-07-03 | 2013-12-17 | P-Cymene bath salt |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013102781557 | 2013-07-03 | ||
| CN201310278155 | 2013-07-03 | ||
| CN201310278155.7 | 2013-07-03 | ||
| CN201310698354.3A CN103655350B (en) | 2013-07-03 | 2013-12-17 | P-Cymene bath salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103655350A true CN103655350A (en) | 2014-03-26 |
| CN103655350B CN103655350B (en) | 2016-11-09 |
Family
ID=50294917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310698354.3A Active CN103655350B (en) | 2013-07-03 | 2013-12-17 | P-Cymene bath salt |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103655350B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105796456A (en) * | 2014-12-31 | 2016-07-27 | 陈军发 | Natural herbal mosquito repellent bath salt |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS557246A (en) * | 1978-06-30 | 1980-01-19 | Kanebo Ltd | Foamable bath salt having improved storage stability |
| CN1559380A (en) * | 2004-03-08 | 2005-01-05 | 浙江大学 | Massage bathing salt |
| CN102764200A (en) * | 2012-07-04 | 2012-11-07 | 江苏天辅星光学材料有限公司 | Bath salt |
-
2013
- 2013-12-17 CN CN201310698354.3A patent/CN103655350B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS557246A (en) * | 1978-06-30 | 1980-01-19 | Kanebo Ltd | Foamable bath salt having improved storage stability |
| CN1559380A (en) * | 2004-03-08 | 2005-01-05 | 浙江大学 | Massage bathing salt |
| CN102764200A (en) * | 2012-07-04 | 2012-11-07 | 江苏天辅星光学材料有限公司 | Bath salt |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105796456A (en) * | 2014-12-31 | 2016-07-27 | 陈军发 | Natural herbal mosquito repellent bath salt |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103655350B (en) | 2016-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103284926B (en) | Cypress essential oil bath salt | |
| CN103284917B (en) | Rose essential oil bath salt | |
| CN103655353A (en) | Melissa officinalis essential oil containing bath salt | |
| CN103315923B (en) | Wheat germ oil bath salt | |
| CN103284924B (en) | Eucalyptus globulus oil bath salt | |
| CN103655350A (en) | Folium mugwort essential oil containing bath salt | |
| CN103340774B (en) | Chamomile essential oil bath salt | |
| CN103315922B (en) | Jojoba oil bath salts | |
| CN103284922B (en) | Clove basil oil bath salt | |
| CN103284921B (en) | Grapefruit oil bath salt | |
| CN103284923B (en) | Lavender oil bath salt | |
| CN103340768B (en) | Peppermint oil bath salt | |
| CN103284894B (en) | Sweet almond oil bath salt | |
| CN103301036B (en) | Sweet orange oil-bath salt | |
| CN103340769B (en) | Pelargonium roseum oil bath salt | |
| CN103284920B (en) | Juniper berry essential oil bath salt | |
| CN103284919B (en) | Tea tree oil bath salt | |
| CN103301037B (en) | Lemon oil bath salt | |
| CN103655352A (en) | Eucalyptus oil bath salt | |
| CN103655344A (en) | Seabuckthorn seed oil containing bath salt | |
| CN103340772B (en) | Rosewood essential-oil bath salt | |
| CN103284925B (en) | Cananga odorata essential oil bath salt | |
| CN103655343A (en) | Osmanthus fragrans essential oil containing bath salt | |
| CN103655351A (en) | Cinnamon essential oil containing bath salt | |
| CN103340771B (en) | Jasmine essential-oil bath salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181207 Address after: 230031 Woye Garden Commercial Building B-2705, 81 Ganquan Road, Shushan District, Hefei City, Anhui Province Patentee after: HEFEI LONGZHIYUN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Address before: 201604 219, room 2, Lane 1000, Tower Road, Shek Hu Town, Songjiang District, Shanghai Patentee before: SHANGHAI BAFANG FINE CHEMICAL ENGINEERING Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20190212 Address after: 314300 Room 411, Yi High School Center, 165 Qinjian South Road, Wuyuan Street, Haiyan County, Jiaxing City, Zhejiang Province Patentee after: Zhejiang Derenai Medical Devices Co.,Ltd. Address before: 230031 Woye Garden Commercial Building B-2705, 81 Ganquan Road, Shushan District, Hefei City, Anhui Province Patentee before: HEFEI LONGZHIYUN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 314300 Room 411, Yi High School Center, 165 Qinjian South Road, Wuyuan Street, Haiyan County, Jiaxing City, Zhejiang Province Patentee after: Zhejiang Chengyi Biotechnology Co.,Ltd. Address before: 314300 Room 411, Yi High School Center, 165 Qinjian South Road, Wuyuan Street, Haiyan County, Jiaxing City, Zhejiang Province Patentee before: Zhejiang Jiuzi Biotechnology Co.,Ltd. Address after: 314300 Room 411, Yi High School Center, 165 Qinjian South Road, Wuyuan Street, Haiyan County, Jiaxing City, Zhejiang Province Patentee after: Zhejiang Jiuzi Biotechnology Co.,Ltd. Address before: 314300 Room 411, Yi High School Center, 165 Qinjian South Road, Wuyuan Street, Haiyan County, Jiaxing City, Zhejiang Province Patentee before: Zhejiang Derenai Medical Devices Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231128 Address after: Building 12, No. 1235, Shendang Section, Nanwang Road, Shendang Town, Haiyan County, Jiaxing City, Zhejiang Province, China, 314311 Patentee after: Zhejiang Qianyeng Biotechnology Co.,Ltd. Address before: 314300 Room 411, Yi High School Center, 165 Qinjian South Road, Wuyuan Street, Haiyan County, Jiaxing City, Zhejiang Province Patentee before: Zhejiang Chengyi Biotechnology Co.,Ltd. |
|
| TR01 | Transfer of patent right |